Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$385M |
| 2 |
Microsoft
MSFT
|
+$368M |
| 3 |
Berkshire Hathaway Class A
BRK.A
|
+$298M |
| 4 |
Delta Air Lines
DAL
|
+$208M |
| 5 |
Carnival Corporation Ltd
CCL
|
+$203M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.34B |
| 2 |
Tesla
TSLA
|
+$353M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$303M |
| 4 |
NVIDIA
NVDA
|
+$290M |
| 5 |
Boeing
BA
|
+$286M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.37% |
| 2 | Healthcare | 18.47% |
| 3 | Consumer Discretionary | 12.41% |
| 4 | Consumer Staples | 10.13% |
| 5 | Industrials | 9.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2451
Vanguard Industrials ETF
VIS
$8.54B
| $799K | ﹤0.01% |
4,100
-600
| -13% | -$123K |
|
2452
Vanguard Morningstar Mid-Cap Value ETF
VOE
$24.6B
| $799K | ﹤0.01% |
6,100
+2,100
| +53% | +$291K |
|
|
ATYR
2453
aTyr Pharma
ATYR
$54.8M
| $799K | ﹤0.01% |
505,993
-20,362
| -4% | -$37.7K |
|
|
TECX
2454
Tectonic Therapeutic
TECX
$682M
| $798K | ﹤0.01% |
43,206
-3,675
| -8% | -$65K |
|
2455
Nomura Holdings
NMR
$28.7B
| $797K | ﹤0.01% |
198,290
-732,900
| -79% | -$2.92M |
|
2456
Rocky Brands
RCKY
$356M
| $796K | ﹤0.01% |
54,135
-7,600
| -12% | -$144K |
|
2457
Fortrea Holdings
FTRE
$1.66B
| $792K | ﹤0.01% |
+27,700
| New | +$820K |
|
2458
Organon & Co
OGN
$3.6B
| $792K | ﹤0.01% |
45,637
-279,863
| -86% | -$5.84M |
|
2459
iShares 10-20 Year Treasury Bond ETF
TLH
$10.8B
| $788K | ﹤0.01% |
+8,000
| New | +$840K |
|
|
CTLP
2460
DELISTED
Cantaloupe
CTLP
| $786K | ﹤0.01% |
125,800
-4,800
| -4% | -$35.2K |
|
2461
Howard Hughes
HHH
$3.98B
| $786K | ﹤0.01% |
11,119
-24,967
| -69% | -$1.88M |
|
2462
MBIA
MBI
$264M
| $783K | ﹤0.01% |
108,559
+54,585
| +101% | +$454K |
|
2463
Invesco CurrencyShares Euro Currency Trust
FXE
$342M
| $782K | ﹤0.01% |
8,000
+100
| +1% | +$10K |
|
2464
Champions Oncology
CSBR
$70.4M
| $781K | ﹤0.01% |
125,791
+900
| +0.7% | +$5.69K |
|
2465
Schwab US Mid-Cap ETF
SCHM
$15.4B
| $778K | ﹤0.01% |
34,500
+16,500
| +92% | +$391K |
|
2466
Invesco S&P Emerging Markets Low Volatility ETF
EELV
$423M
| $772K | ﹤0.01% |
34,300
-21,500
| -39% | -$506K |
|
2467
iShares MSCI Pacific ex Japan ETF
EPP
$2.24B
| $772K | ﹤0.01% |
19,400
-24,100
| -55% | -$998K |
|
|
ZYNE
2468
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
| $772K | ﹤0.01% |
605,700
-84,013
| -12% | -$73.4K |
|
2469
Broadstone Net Lease
BNL
$4.38B
| $771K | ﹤0.01% |
53,900
-9,000
| -14% | -$144K |
|
2470
Hippo Holdings
HIPO
$872M
| $770K | ﹤0.01% |
96,604
+15,300
| +19% | +$192K |
|
2471
Cartesian Therapeutics
RNAC
$267M
| $770K | ﹤0.01% |
24,200
-9,217
| -28% | -$308K |
|
2472
iShares Core Moderate Allocation ETF
AOM
$1.78B
| $767K | ﹤0.01% |
19,700
-14,800
| -43% | -$592K |
|
2473
Hydrofarm Holdings
HYFM
$7M
| $767K | ﹤0.01% |
62,890
+1,110
| +2% | +$12.4K |
|
2474
Spruce Power Holding Corp
SPRU
$33.8M
| $766K | ﹤0.01% |
140,750
+3,525
| +3% | +$23.4K |
|
2475
iShares Currency Hedged MSCI EAFE ETF
HEFA
$7.79B
| $765K | ﹤0.01% |
25,400
-25,300
| -50% | -$766K |
|
Similar funds
Jim Simons's Q3 2023 Portfolio in Review
As of Q3 2023, Jim Simons held 4,329 positions worth $58.7B, down 15% from $69.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons withdrew a net $8.34B in Q3 2023, closing 713 positions and reducing 1,794 holdings. Its most notable exit was Chevron, an estimated $185M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jim Simons opened a new position in D.R. Horton worth $125M.
- Jim Simons's largest Q3 2023 buy was D.R. Horton: 1,159,438 shares worth $125M.
- Jim Simons added most to Netflix in Q3 2023, an estimated $385M increase.
- Jim Simons's biggest Q3 2023 reduction was Meta Platforms (Facebook), cutting an estimated $1.34B.
- Jim Simons fully exited Chevron in Q3 2023, selling an estimated $185M.
- Jim Simons's ten largest holdings make up 12% of its $58.7B portfolio in Q3 2023.
- Jim Simons opened 464 new positions and closed 713 in Q3 2023.
- Jim Simons's portfolio value fell 15% quarter-over-quarter to $58.7B.
Based on Renaissance Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.